Market News
Stay updated with the latest market trends, earnings, and economic indicators.
NITI Aayog begins consultations on implementing SHANTI Act
NITI Aayog convened a consultation on the SHANTI Act, 2025, allowing private nuclear energy plant ownership. Discussions focused on draft rules, regulations, and FDI policy provisions for the new law. Stakeholders examined financial mechanisms and risk mitigation frameworks for project support. The Act aims to modernize nuclear laws and boost clean energy transition. It also strengthens regulatory oversight and domestic manufacturing capabilities for nuclear projects.
Stock Picks Today: Canara Bank, Airtel, Colgate, Dabur, Clean Max, Ambuja, NHPC, And More On Brokerages' Radar
Brokerages' Radar
Industry wants to build nuclear reactors in India, possible with SHANTI Act: US delegate
The SHANTI Act of 2025 has significantly boosted opportunities for US commercial nuclear companies to collaborate with India. A high-level US delegation, including NEI's CEO Maria Korsnick, met with Indian ministers to discuss expanding clean energy cooperation. Korsnick highlighted the US's advanced reactor technologies and expressed readiness to partner with India based on its specific needs.
Stocks to Watch Today: JK Lakshmi Cement, Gravita India, Balaji Amines, Shaily Engineering, Kalpataru, Action Construction Equipment in focus on 13 March
Stocks to Watch, 13 March: Stocks like Shaily Engineering Plastics, JK Lakshmi Cement, Max Financial Services, Manorama Industries, Nectar Lifesciences, Balaji Amines, and KPI Green Energy will be in focus on March 13.
Stocks to Watch Today: HDFC Bank, Yes Bank, Dabur, Senco Gold, Nykaa, Shakti Pumps, GK Energy, Rubicon Research, Manappuram, Enviro Infra in focus on 06 July
Stocks to Watch, 6 Jul: Stocks like HDFC Bank, Kotak Mahindra Bank, IndusInd Bank, Yes Bank, CreditAccess Grameen, RBL Bank, IDBI Bank, FSN E-Commerce Ventures Nykaa, Senco Gold, Dabur India, Godrej Consumer Products, GK Energy,Shakti Pumps (India), Innovision, PTC India, and Bliss GVS Pharma will be in focus on July 6.